SCHEMBL1004145

SCHEMBL1004145

CCCC(C)Oc1cc[c]cc1

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.36
P2RX3 P56373 8/20 0.32
GPR88 Q9GZN0 1/20 0.32
SIGMAR1 Q99720 2/20 0.32
MTNR1A P48039 2/20 0.32
MTNR1B P49286 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28897940 0.85 ALDH1A1 (0.42) GPR88
SCHEMBL533652 0.83 ACACB (0.37) MCHR1MTNR1AMTNR1B
SCHEMBL9988719 0.83 ACACB (0.37) MCHR1MTNR1AMTNR1B
SCHEMBL1005061 0.82 PPARG (0.30)
SCHEMBL1454240 0.79 MTNR1A (0.49) MCHR1GPR88MTNR1AMTNR1B
SCHEMBL28358697 0.78 PPARG (0.32)
SCHEMBL5273491 0.78 MCHR1 (0.36) MCHR1P2RX3GPR88MTNR1AMTNR1B
SCHEMBL27566411 0.78 P2RX3 (0.42) MCHR1P2RX3SIGMAR1
SCHEMBL2088447 0.77 ACACB (0.37) MTNR1AMTNR1B
SCHEMBL13657967 0.76 GPR88 (0.40) MCHR1GPR88SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1548020-B1 SILICON COMPOUND JNC CORP (JP) 2014-07-23 EP disclosed
EP-1550664-B1 SILICON COMPOUND JNC CORP (JP) 2012-06-27 EP disclosed
US-7964692-B2 Polymer obtained by addition-polymerization initiated by a silicon compound JNC CORPORATION (JP) 2011-06-21 US disclosed
US-7863396-B2 Silicon compounds CHISSO CORPORATION (JP) 2011-01-04 US disclosed
US-7662985-B2 Polysilsesquioxanes; addition-condensation copolymers CHISSO CORPORATION (JP) 2010-02-16 US disclosed
EP-1650214-B1 Silicon compound CHISSO CORP (JP) 2009-11-04 EP disclosed
US-7563917-B2 Silicon compound and a production process for silicon compound CHISSO CORPORATION (JP) 2009-07-21 US disclosed
US-20090143606-A1 Production process for a silicon compound JNC CORPORATION (JP) 2009-06-04 US disclosed
US-20090137765-A1 Polymer obtained by addition-polymerization initiated by a silicon compound JNC CORPORATION (JP) 2009-05-28 US disclosed
EP-1686133-B1 Organosilicon compound CHISSO CORP (JP) 2008-08-20 EP disclosed
US-20060094849-A1 Silicon compound JNC CORPORATION (JP) 2006-05-04 US disclosed
EP-1650214-A2 Silicon compound CHISSO CORPORATION (JP) 2006-04-26 EP disclosed
US-20050288468-A1 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers JNC CORPORATION (JP) 2005-12-29 US disclosed
US-20050250925-A1 Silicon compound JNC CORPORATION (JP) 2005-11-10 US disclosed
EP-1550664-A1 SILICON COMPOUND CHISSO CORPORATION (JP) 2005-07-06 EP disclosed
EP-1548020-A1 SILICON COMPOUND CHISSO CORPORATION (JP) 2005-06-29 EP disclosed
US-20050033077-A1 Production process for silicon compound and the same JNC CORPORATION (JP) 2005-02-10 US disclosed
US-20040143081-A1 Novel silicon compounds and process for preparation thereof JNC CORPORATION (JP) 2004-07-22 US disclosed
US-4610804-A Anthraquinone dyes and liquid crystal compositions including the same HITACHI, LTD. (JP) 1986-09-09 US disclosed
EP-0120463-A2 Anthraquinone dyes and liquid crystal compositions including the same HITACHI, LTD. (JP) 1984-10-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143606-A1 Production process for a silicon compound NAF1, H1-0, SPTBN1 MCHR1 1749/4885P2RX3 4508/4885GPR88 2761/4885
US-20050288468-A1 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers STS, SULT1A1, SRM MCHR1 4194/4885P2RX3 1061/4885GPR88 2019/4885
US-20050033077-A1 Production process for silicon compound and the same STS, SMS, SFXN1 MCHR1 3283/4885P2RX3 2177/4885GPR88 1700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.